- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Cosmo Pharmaceuticals SpA+ Add to Watchlist
COPN:SW102.80 CHF 0.80 0.78%
As of 12:43:49 ET on 03/14/2014.
Company Profile for Cosmo Pharmaceuticals SpA (COPN)
Cosmo Pharmaceuticals SpA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.
Cosmo Pharmaceuticals SpA
Key Executives for Cosmo Pharmaceuticals SpA (COPN)
|Mauro Severino AjaniChairman/CEO/Founder||Hans Christoph TannerChief Financial Officer|
|Marco LecchiDeputy Chief Financial Officer||Guiseppe CiprianoChief Operating Officer|
|Luigi MoroChief Scientific Officer||Guiseppe CelascoChief Medical Officer|
|Roberto VillaChief Manufacturing Officer|